GovChime
UEI: J6ZQV1E66G99 • CAGE: 499Y3

TRANSPOSAGEN BIOPHARMACEUTICALS, INC. (KY)

Registration and award facts

SAM.gov registration as of

Net obligations since FY2012
$56.3K
$56,301under this UEI
FY2026 obligations
$0
Provisional
Awards and orders
3
with positive net obligations
Latest action
May 7, 2014
SAM.gov registration
Inactive
Registration expiration date Aug 13, 2019

Registration

Entity structure
Corporate Entity (Not Tax Exempt)
Business start date
Oct 31, 2003 (22 years)
Location
Lexington, KY
State of incorporation
Delaware
Purpose of registration
All Awards

† FY2026 obligations (provisional; DoD awards signed after Jul 30, 2026 are not yet public).

Source: SAM.gov entity registration and FPDS contract actions recorded under UEI J6ZQV1E66G99. GovChime does not check exclusions.

Performance

Net obligations recorded under this UEI since FY2012. Top lists show the largest five by share of this vendor's net obligations; the shares do not sum to 100%.

Net obligations by fiscal year of action

  • FY2014: $36,184
  • FY2012: $20,117

Total across 2 fiscal years: $56,301

Top awarding agencies

Top awarding sub-agencies

Top NAICS by obligations

Top product and service codes by obligations

  • Q301Medical- laboratory testing$42,117, 74.8%
  • 6505Drugs and biologicals$14,184, 25.2%

Capabilities

Contracts

Latest awards and orders

  1. HHSN268201400131PPurchase orderDepartment of Health and Human ServicesNational Institutes of HealthLatest action
  2. HHSN271201400174PPoDepartment of Health and Human ServicesNational Institutes of HealthLatest action
  3. HHSN268201200326PPoDepartment of Health and Human ServicesNational Institutes of HealthLatest action

Contact Info

As of . Source: SAM.gov Points of Contact.

SAM.gov registration for TRANSPOSAGEN BIOPHARMACEUTICALS, INC. lists a physical address and a separate mailing address, along with 6 verified points of contact. Past Performance contacts are the recommended outreach channel for due-diligence references; Government Business contacts handle procurement-facing correspondence.

Source: SAM.gov entity registration. Contacts displaying numeric or placeholder names have been filtered (defense-in-depth).

Physical Address

203 W 2ND ST STE 1

LEXINGTON, KY, 40507

USA

Mailing Address

535 West Second Street

Suite L10

LEXINGTON, KY, 40508

USA

Government Business Contact

Angie Allen

535 West Second Street

Suite L10

LEXINGTON, KY, 40508

USA

Electronic Business Contact

Angie Allen

535 West Second Street

Suite L10

LEXINGTON, KY, 40508

USA

Past Performance Contact

ERIC ostertag

535 West Second Street

Lexington, KY, 40508

USA

Government Business Alternate Contact

John Printen

535 West Second Street

LEXINGTON, KY, 40508

USA

Electronic Business Alternate Contact

John Printen

535 West Second Street

LEXINGTON, KY, 40508

USA

Past Performance Alternate Contact

ERIC ostertag

535 West Second Street

Lexington, KY, 40508

USA

Additional Details

As of . Source: SAM.gov Entity Registration.

TRANSPOSAGEN BIOPHARMACEUTICALS, INC. has no active federal suspension or debarment on record in SAM.gov. Current SAM.gov registration expires August 13, 2019.

Source: SAM.gov entity registration (FAR responses, registration status). Always verify active exclusions against the authoritative record on SAM.gov before contract award.

Compliance & Risk Assessment

Source: SAM.gov FAR responses

Suspension/Debarment Status

SAM.gov registration reports no active exclusion

Public Display

Entity information is publicly displayed

Disaster Relief Registry

Not registered for disaster relief

Bonding Information

No bonding information provided

EDI

Not declared in SAM.gov

Business Structure

Source: SAM.gov
Profit Structure:For Profit Organization

Registration Details

Source: SAM.gov

Initial Registration

Jan 9, 2006

Last Update

Sep 23, 2021

Registration Activation

Active — Aug 13, 2018

Fiscal Year End

12/31

Country of Incorporation

USA

Congressional District

06